This website uses cookies to improve your experience. Learn more about cookies and how to manage them.

Key aspects of modern drug discovery

Designed and delivered by experts from industry and academia, this training event will provide a comprehensive overview of the pre-clinical drug discovery process. The workshop will focus on small molecule target identification and validation, hit-to-lead and lead optimisation, as well as on pre-clinical drug development and toxicology.

17–18 Oct 2019

Abstracts deadline:

Registration deadline:

BioCity, Nottingham, UK - View map

  • Overview

The programme will include lectures, case studies and group discussions, providing great networking opportunities and encouraging collaboration among delegates and speakers.

Programme Coordinators:

  • Rick Davies, AstraZeneca
  • Jacqui Piner, GSK
  • John Unitt, Sygnature Discovery
  • Heather Wallace, University of Aberdeen
  • John Ladbury, University of Leeds
  • John Colyer, University of Leeds

The event is sponsored by the Royal Society of Chemistry, and supported by the British Pharmacological Society and the Royal Society of Biology.

Last year this event sold out, so register now to avoid disappointment!